Search research articles
Contact Us
Filters
Showing results (181-190 of 195) with videos related to
Page
of 20
Sort By:
Frontiers in Pharmacology
|
May 31, 2024
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells
Emily M Esquea, Lorela Ciraku, Riley G Young, et al.
JCO Oncology Practice
|
September 24, 2025
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines
Paula M Fracasso, Nicole L Simone, Stephanie J Si Lim, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 21, 2013
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS
Ettore Beghi, Elisabetta Pupillo, Virginio Bonito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2011
Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer
Athanassios Argiris, Austin G Duffy, Shivaani Kummar, et al.
European Journal of Neurology
|
July 2, 2009
An exploration of anger phenomenology in multiple sclerosis
U Nocentini, G Tedeschi, R Migliaccio, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2017
NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence
Douglas W Arthur, Kathryn A Winter, Henry M Kuerer, et al.
Annals of Neurology
|
October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis
M Trojano, F Pellegrini, D Paolicelli, et al.
Neurology
|
August 13, 2010
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial
A Chiò, G Borghero, A Calvo, et al.
Journal of the Neurological Sciences
|
July 21, 2009
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment
M Trojano, F Pellegrini, D Paolicelli, et al.
Neurology
|
July 27, 2005
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
G Tedeschi, L Lavorgna, P Russo, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 195) with videos related to
Sort By:
Page
of 20
Frontiers in Pharmacology
|
May 31, 2024
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells
Emily M Esquea, Lorela Ciraku, Riley G Young, et al.
JCO Oncology Practice
|
September 24, 2025
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines
Paula M Fracasso, Nicole L Simone, Stephanie J Si Lim, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 21, 2013
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS
Ettore Beghi, Elisabetta Pupillo, Virginio Bonito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2011
Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer
Athanassios Argiris, Austin G Duffy, Shivaani Kummar, et al.
European Journal of Neurology
|
July 2, 2009
An exploration of anger phenomenology in multiple sclerosis
U Nocentini, G Tedeschi, R Migliaccio, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2017
NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence
Douglas W Arthur, Kathryn A Winter, Henry M Kuerer, et al.
Annals of Neurology
|
October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis
M Trojano, F Pellegrini, D Paolicelli, et al.
Neurology
|
August 13, 2010
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial
A Chiò, G Borghero, A Calvo, et al.
Journal of the Neurological Sciences
|
July 21, 2009
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment
M Trojano, F Pellegrini, D Paolicelli, et al.
Neurology
|
July 27, 2005
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
G Tedeschi, L Lavorgna, P Russo, et al.
Page
of 20